Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b-Reference-Cited by-同舟云学术

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Published:2015-12-14 Issue:4 Volume:7 Page:4428-4441
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Vergani Elisabetta¹,Di Guardo Lorenza²,Dugo Matteo³,Rigoletto Sara¹,Tragni Gabrina⁴,Ruggeri Roberta⁵,Perrone Federica⁴,Tamborini Elena⁴,Gloghini Annunziata⁴,Arienti Flavio⁶,Vergani Barbara⁷,Deho Paola¹,De Cecco Loris³,Vallacchi Viviana¹,Frati Paola¹,Shahaj Eriomina¹,Villa Antonello⁷,Santinami Mario⁵,De Braud Filippo²,Rivoltini Licia¹,Rodolfo Monica¹

Affiliation:

1. Immunotherapy Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

3. Functional Genomics and Bioinformatics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

4. Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

5. Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

6. Immunohematology and Transfusion Medicine Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

7. Consorzio MIA, Microscopy and Image Analysis, University of Milan Bicocca, Monza, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib);Cell Communication and Signaling;2024-08-23

2. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21

3. Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy;Journal of Experimental & Clinical Cancer Research;2024-08-15

4. Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors;Frontiers in Immunology;2024-06-05

5. Role of microRNA-146a in cancer development by regulating apoptosis;Pathology - Research and Practice;2024-02